Related Experiment Video
Updated: Oct 1, 2026

05:22
Ex vivo Culture of Human Placental Explants for the Study of Viral Transmission Across the Maternal-Fetal Interface
Published on: December 30, 2025
A framework for assessing potential Oropouche virus-associated adverse fetal outcomes
Luísa Freire Tanaka1, Nayele Benittes de Moura Dutra1, Thaísa Regina Rocha Lopes1,2
1Laboratório NB3 de Neuroimunologia, Universidade Federal de Santa Maria, Santa Maria, Rio Grande do Sul, Brazil.
BMC Infectious Diseases
|September 29, 2026
Abstract:
Several reports have suggested Oropouche virus (OROV)-related vertical transmission and adverse fetal outcomes; however, these observations require further investigation. Herein, we propose complementary experimental and epidemiological approaches to better characterize the potential role of OROV infection in fetal and neonatal disorders.
Related Concept Videos
Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
